

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | striated muscle hypertrophy (GO:0014897) | 4.69709023 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.60562451 |
| 3 | vocalization behavior (GO:0071625) | 4.51697877 |
| 4 | sulfation (GO:0051923) | 4.50198891 |
| 5 | otic vesicle formation (GO:0030916) | 4.43042270 |
| 6 | epithelial cell differentiation involved in kidney development (GO:0035850) | 4.38511745 |
| 7 | tryptophan metabolic process (GO:0006568) | 4.37090773 |
| 8 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.34342201 |
| 9 | pharyngeal system development (GO:0060037) | 4.31344664 |
| 10 | serotonin metabolic process (GO:0042428) | 4.27566526 |
| 11 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.23251223 |
| 12 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.22015565 |
| 13 | protein localization to synapse (GO:0035418) | 4.20731530 |
| 14 | muscle hypertrophy (GO:0014896) | 4.18980035 |
| 15 | regulation of phospholipid biosynthetic process (GO:0071071) | 4.18207577 |
| 16 | positive regulation of fatty acid oxidation (GO:0046321) | 4.10296749 |
| 17 | cell proliferation in forebrain (GO:0021846) | 4.10149797 |
| 18 | glutamate secretion (GO:0014047) | 4.07890431 |
| 19 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 4.07721433 |
| 20 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.04715459 |
| 21 | synaptic vesicle exocytosis (GO:0016079) | 4.01861479 |
| 22 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.01506867 |
| 23 | cellular potassium ion homeostasis (GO:0030007) | 3.97656173 |
| 24 | neuron cell-cell adhesion (GO:0007158) | 3.91979744 |
| 25 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.86862655 |
| 26 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.85136027 |
| 27 | regulation of cell proliferation involved in kidney development (GO:1901722) | 3.82625059 |
| 28 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.82076728 |
| 29 | locomotory exploration behavior (GO:0035641) | 3.81085064 |
| 30 | glutamate receptor signaling pathway (GO:0007215) | 3.79352575 |
| 31 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.77185530 |
| 32 | regulation of glomerulus development (GO:0090192) | 3.70449677 |
| 33 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.70247400 |
| 34 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.68745484 |
| 35 | indolalkylamine metabolic process (GO:0006586) | 3.66232615 |
| 36 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.60867623 |
| 37 | presynaptic membrane assembly (GO:0097105) | 3.60696204 |
| 38 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.59982816 |
| 39 | kynurenine metabolic process (GO:0070189) | 3.55843792 |
| 40 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.53776260 |
| 41 | primary amino compound metabolic process (GO:1901160) | 3.53245946 |
| 42 | neuronal action potential propagation (GO:0019227) | 3.52346625 |
| 43 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.46598867 |
| 44 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.44018236 |
| 45 | synaptic vesicle maturation (GO:0016188) | 3.43365116 |
| 46 | regulation of synaptic vesicle transport (GO:1902803) | 3.42486455 |
| 47 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.40268982 |
| 48 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.32485543 |
| 49 | striated muscle adaptation (GO:0014888) | 3.32427086 |
| 50 | cell communication by electrical coupling (GO:0010644) | 3.32412443 |
| 51 | neuron-neuron synaptic transmission (GO:0007270) | 3.29596263 |
| 52 | synaptic transmission, glutamatergic (GO:0035249) | 3.24568075 |
| 53 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.24321208 |
| 54 | indole-containing compound metabolic process (GO:0042430) | 3.23841913 |
| 55 | neuron recognition (GO:0008038) | 3.23216351 |
| 56 | behavioral response to nicotine (GO:0035095) | 3.23029087 |
| 57 | cochlea development (GO:0090102) | 3.22264694 |
| 58 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.21322586 |
| 59 | retinal cone cell development (GO:0046549) | 3.20880226 |
| 60 | response to histamine (GO:0034776) | 3.20733754 |
| 61 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.20659242 |
| 62 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 3.20626747 |
| 63 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 3.20626747 |
| 64 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.19750937 |
| 65 | forebrain neuron development (GO:0021884) | 3.17258928 |
| 66 | regulation of sequestering of triglyceride (GO:0010889) | 3.15954840 |
| 67 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.15823761 |
| 68 | tryptophan catabolic process (GO:0006569) | 3.15355647 |
| 69 | indole-containing compound catabolic process (GO:0042436) | 3.15355647 |
| 70 | indolalkylamine catabolic process (GO:0046218) | 3.15355647 |
| 71 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.13692976 |
| 72 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.13485054 |
| 73 | regulation of hippo signaling (GO:0035330) | 3.13428589 |
| 74 | presynaptic membrane organization (GO:0097090) | 3.13140426 |
| 75 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.12635107 |
| 76 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.12635107 |
| 77 | NADH dehydrogenase complex assembly (GO:0010257) | 3.12635107 |
| 78 | cerebellar granule cell differentiation (GO:0021707) | 3.12119188 |
| 79 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.11402935 |
| 80 | exploration behavior (GO:0035640) | 3.11186413 |
| 81 | postsynaptic membrane organization (GO:0001941) | 3.10305262 |
| 82 | * regulation of postsynaptic membrane potential (GO:0060078) | 3.07888271 |
| 83 | long-term synaptic potentiation (GO:0060291) | 3.06018389 |
| 84 | detection of calcium ion (GO:0005513) | 3.05464147 |
| 85 | negative regulation of gene silencing (GO:0060969) | 3.04387654 |
| 86 | positive regulation of neurotransmitter transport (GO:0051590) | 3.03408294 |
| 87 | regulation of DNA endoreduplication (GO:0032875) | 3.00183643 |
| 88 | long-term memory (GO:0007616) | 2.99450489 |
| 89 | behavioral response to cocaine (GO:0048148) | 2.97250846 |
| 90 | neurotransmitter secretion (GO:0007269) | 2.96580389 |
| 91 | activation of protein kinase A activity (GO:0034199) | 2.96095070 |
| 92 | adult heart development (GO:0007512) | 2.95502305 |
| 93 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.94485259 |
| 94 | epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198) | 2.91841220 |
| 95 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.90380109 |
| 96 | regulation of synapse structural plasticity (GO:0051823) | 2.89705769 |
| 97 | neuromuscular process controlling posture (GO:0050884) | 2.89374598 |
| 98 | regulation of synaptic plasticity (GO:0048167) | 2.89068756 |
| 99 | norepinephrine metabolic process (GO:0042415) | 2.89034926 |
| 100 | negative regulation of platelet activation (GO:0010544) | 2.87995013 |
| 101 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.87798254 |
| 102 | sodium ion export (GO:0071436) | 2.86872761 |
| 103 | * regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.86798074 |
| 104 | cellular response to ATP (GO:0071318) | 2.85881552 |
| 105 | axonal fasciculation (GO:0007413) | 2.84138886 |
| 106 | regulation of dendritic spine development (GO:0060998) | 2.84079209 |
| 107 | behavioral fear response (GO:0001662) | 2.82546100 |
| 108 | behavioral defense response (GO:0002209) | 2.82546100 |
| 109 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.82543923 |
| 110 | relaxation of cardiac muscle (GO:0055119) | 2.82508305 |
| 111 | cytidine metabolic process (GO:0046087) | 2.81575377 |
| 112 | cytidine catabolic process (GO:0006216) | 2.81575377 |
| 113 | cytidine deamination (GO:0009972) | 2.81575377 |
| 114 | layer formation in cerebral cortex (GO:0021819) | 2.81252542 |
| 115 | cell communication involved in cardiac conduction (GO:0086065) | 2.79355526 |
| 116 | gamma-aminobutyric acid transport (GO:0015812) | 2.79316719 |
| 117 | protein complex biogenesis (GO:0070271) | 2.79133940 |
| 118 | potassium ion import (GO:0010107) | 2.77849776 |
| 119 | regulation of vesicle fusion (GO:0031338) | 2.76801876 |
| 120 | lymphangiogenesis (GO:0001946) | 2.75421674 |
| 121 | negative regulation of peptidyl-lysine acetylation (GO:2000757) | 2.75288346 |
| 122 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.72299853 |
| 123 | artery development (GO:0060840) | 2.71274138 |
| 124 | dorsal/ventral axis specification (GO:0009950) | 2.70865608 |
| 125 | flavonoid metabolic process (GO:0009812) | 2.70689632 |
| 126 | thyroid hormone metabolic process (GO:0042403) | 2.70600460 |
| 127 | innervation (GO:0060384) | 2.69844448 |
| 128 | dendritic spine morphogenesis (GO:0060997) | 2.67565207 |
| 129 | regulation of action potential (GO:0098900) | 2.66304597 |
| 130 | regulation of fatty acid oxidation (GO:0046320) | 2.65783141 |
| 131 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.65260606 |
| 132 | positive regulation of synapse maturation (GO:0090129) | 2.64668011 |
| 133 | positive regulation of membrane potential (GO:0045838) | 2.64372636 |
| 134 | membrane depolarization (GO:0051899) | 2.64250499 |
| 135 | * fear response (GO:0042596) | 2.64035273 |
| 136 | regulation of oxidative phosphorylation (GO:0002082) | 2.63999295 |
| 137 | positive regulation of metanephros development (GO:0072216) | 2.63389272 |
| 138 | regulation of membrane repolarization (GO:0060306) | 2.63106421 |
| 139 | membrane depolarization during action potential (GO:0086010) | 2.62158468 |
| 140 | * adrenergic receptor signaling pathway (GO:0071875) | 2.62080727 |
| 141 | regulation of cell communication by electrical coupling (GO:0010649) | 2.61639532 |
| 142 | neuronal action potential (GO:0019228) | 2.60027390 |
| 143 | regulation of neurotransmitter secretion (GO:0046928) | 2.59506396 |
| 144 | neurotransmitter transport (GO:0006836) | 2.59430817 |
| 145 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.57367885 |
| 146 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.56557011 |
| 147 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.55507764 |
| 148 | synaptic vesicle endocytosis (GO:0048488) | 2.55024996 |
| 149 | cardiac muscle hypertrophy (GO:0003300) | 2.54966501 |
| 150 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.54935583 |
| 151 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.54935583 |
| 152 | long term synaptic depression (GO:0060292) | 2.54846253 |
| 153 | muscle adaptation (GO:0043500) | 2.54535929 |
| 154 | heparin metabolic process (GO:0030202) | 2.53457603 |
| 155 | heparin biosynthetic process (GO:0030210) | 2.53457603 |
| 156 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.51818572 |
| 157 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.51717474 |
| 158 | muscle hypertrophy in response to stress (GO:0003299) | 2.51717474 |
| 159 | cardiac muscle adaptation (GO:0014887) | 2.51717474 |
| 160 | cardiac myofibril assembly (GO:0055003) | 2.51593990 |
| 161 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.51047722 |
| 162 | startle response (GO:0001964) | 2.48980712 |
| 163 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.48501753 |
| 164 | positive regulation of synapse assembly (GO:0051965) | 2.47334218 |
| 165 | multicellular organismal movement (GO:0050879) | 2.46849044 |
| 166 | musculoskeletal movement (GO:0050881) | 2.46849044 |
| 167 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.43969597 |
| 168 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.43969597 |
| 169 | cardiac conduction (GO:0061337) | 2.43643611 |
| 170 | phenol-containing compound catabolic process (GO:0019336) | 2.41192762 |
| 171 | hair cycle (GO:0042633) | 2.40829548 |
| 172 | molting cycle (GO:0042303) | 2.40829548 |
| 173 | negative regulation of cardiac muscle tissue development (GO:0055026) | 2.40640124 |
| 174 | cell differentiation in hindbrain (GO:0021533) | 2.40441864 |
| 175 | multicellular organismal signaling (GO:0035637) | 2.39554844 |
| 176 | estrogen metabolic process (GO:0008210) | 2.37188100 |
| 177 | regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358) | 2.36719175 |
| 178 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.36660484 |
| 179 | negative regulation of response to food (GO:0032096) | 2.36545059 |
| 180 | negative regulation of appetite (GO:0032099) | 2.36545059 |
| 181 | protein polyglutamylation (GO:0018095) | 2.36071528 |
| 182 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 2.34622467 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 9.17085110 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.05045212 |
| 3 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 4.00630688 |
| 4 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.65251259 |
| 5 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 3.19155595 |
| 6 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.04346675 |
| 7 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.00305904 |
| 8 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.81219357 |
| 9 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.80697361 |
| 10 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.59629551 |
| 11 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.57531527 |
| 12 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.57531527 |
| 13 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.53313306 |
| 14 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.48670949 |
| 15 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.39517223 |
| 16 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.39352291 |
| 17 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.39179530 |
| 18 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.32831445 |
| 19 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.27045329 |
| 20 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.14198302 |
| 21 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.02527739 |
| 22 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.01706083 |
| 23 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.00558990 |
| 24 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.99116938 |
| 25 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.98474252 |
| 26 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.98002254 |
| 27 | VDR_22108803_ChIP-Seq_LS180_Human | 1.94309181 |
| 28 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.78975881 |
| 29 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.72712184 |
| 30 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.72259492 |
| 31 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.71095736 |
| 32 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.68447103 |
| 33 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.62167951 |
| 34 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.61223571 |
| 35 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.58960997 |
| 36 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.54955750 |
| 37 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.52948796 |
| 38 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.51082473 |
| 39 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.49583534 |
| 40 | P300_19829295_ChIP-Seq_ESCs_Human | 1.44511067 |
| 41 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.43485740 |
| 42 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.43309609 |
| 43 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.42948739 |
| 44 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.42133583 |
| 45 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.42028298 |
| 46 | * PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.40372803 |
| 47 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.39850875 |
| 48 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.36469956 |
| 49 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.36440706 |
| 50 | * TP53_16413492_ChIP-PET_HCT116_Human | 1.36375408 |
| 51 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.36113876 |
| 52 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.35731821 |
| 53 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.35234818 |
| 54 | EWS_26573619_Chip-Seq_HEK293_Human | 1.32101727 |
| 55 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.31788104 |
| 56 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.31350172 |
| 57 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.31018014 |
| 58 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.30740745 |
| 59 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.28815389 |
| 60 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.27730896 |
| 61 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.26990089 |
| 62 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.24457095 |
| 63 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.22986654 |
| 64 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.22983831 |
| 65 | AR_25329375_ChIP-Seq_VCAP_Human | 1.22949458 |
| 66 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.21972744 |
| 67 | * CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.21791602 |
| 68 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.20732449 |
| 69 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.20415709 |
| 70 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.19635939 |
| 71 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.17945359 |
| 72 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.17103168 |
| 73 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.16144977 |
| 74 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.15888079 |
| 75 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.15546647 |
| 76 | * AR_19668381_ChIP-Seq_PC3_Human | 1.14937850 |
| 77 | FUS_26573619_Chip-Seq_HEK293_Human | 1.14737480 |
| 78 | STAT3_23295773_ChIP-Seq_U87_Human | 1.14158009 |
| 79 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 1.13818897 |
| 80 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.13686002 |
| 81 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.13267133 |
| 82 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.12245073 |
| 83 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.12069208 |
| 84 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.11808369 |
| 85 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.10308201 |
| 86 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.09648832 |
| 87 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.09454449 |
| 88 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.09074114 |
| 89 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.07993805 |
| 90 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.07480774 |
| 91 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.06487710 |
| 92 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.04772758 |
| 93 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.04423765 |
| 94 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.04398324 |
| 95 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.01585725 |
| 96 | TCF4_23295773_ChIP-Seq_U87_Human | 0.99511539 |
| 97 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.99202181 |
| 98 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.98809895 |
| 99 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.98333354 |
| 100 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.98291720 |
| 101 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.97803913 |
| 102 | RXR_22108803_ChIP-Seq_LS180_Human | 0.96495811 |
| 103 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.95580857 |
| 104 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.93847910 |
| 105 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.92148287 |
| 106 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.91826490 |
| 107 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.91467102 |
| 108 | * MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.90647292 |
| 109 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.90593461 |
| 110 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.90494563 |
| 111 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89025839 |
| 112 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.89025839 |
| 113 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88750919 |
| 114 | * KDM2B_26808549_Chip-Seq_REH_Human | 0.87777325 |
| 115 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.87420935 |
| 116 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.86490256 |
| 117 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.86322230 |
| 118 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.86204157 |
| 119 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.86130912 |
| 120 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.85763357 |
| 121 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.85142877 |
| 122 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.85105105 |
| 123 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.84996592 |
| 124 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.84532934 |
| 125 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.84342789 |
| 126 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.84131020 |
| 127 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.82328701 |
| 128 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.81648677 |
| 129 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.80216772 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.00015462 |
| 2 | MP0003880_abnormal_central_pattern | 4.88035377 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.49178166 |
| 4 | MP0002837_dystrophic_cardiac_calcinosis | 3.21556585 |
| 5 | MP0005171_absent_coat_pigmentation | 3.20057843 |
| 6 | MP0009745_abnormal_behavioral_response | 3.03419200 |
| 7 | MP0004270_analgesia | 3.02200638 |
| 8 | MP0002063_abnormal_learning/memory/cond | 2.75543691 |
| 9 | MP0002064_seizures | 2.72625424 |
| 10 | MP0001968_abnormal_touch/_nociception | 2.59399938 |
| 11 | MP0005670_abnormal_white_adipose | 2.48486575 |
| 12 | MP0004215_abnormal_myocardial_fiber | 2.41782825 |
| 13 | MP0002572_abnormal_emotion/affect_behav | 2.37436222 |
| 14 | MP0009046_muscle_twitch | 2.36816312 |
| 15 | MP0001485_abnormal_pinna_reflex | 2.33938525 |
| 16 | MP0005083_abnormal_biliary_tract | 2.30147366 |
| 17 | MP0001501_abnormal_sleep_pattern | 2.26937936 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 2.25576814 |
| 19 | MP0001486_abnormal_startle_reflex | 2.21171730 |
| 20 | MP0005551_abnormal_eye_electrophysiolog | 2.18666198 |
| 21 | MP0002272_abnormal_nervous_system | 2.14600463 |
| 22 | MP0000751_myopathy | 2.14509704 |
| 23 | MP0002736_abnormal_nociception_after | 2.14234940 |
| 24 | MP0006292_abnormal_olfactory_placode | 2.13140435 |
| 25 | MP0002163_abnormal_gland_morphology | 2.09898053 |
| 26 | MP0004134_abnormal_chest_morphology | 2.07746094 |
| 27 | MP0005503_abnormal_tendon_morphology | 2.04055617 |
| 28 | MP0005423_abnormal_somatic_nervous | 1.96216805 |
| 29 | MP0001440_abnormal_grooming_behavior | 1.92569843 |
| 30 | MP0009780_abnormal_chondrocyte_physiolo | 1.83753268 |
| 31 | MP0004484_altered_response_of | 1.82262103 |
| 32 | MP0000631_abnormal_neuroendocrine_gland | 1.81276998 |
| 33 | MP0003329_amyloid_beta_deposits | 1.79796807 |
| 34 | MP0002067_abnormal_sensory_capabilities | 1.73647237 |
| 35 | MP0002295_abnormal_pulmonary_circulatio | 1.73607725 |
| 36 | MP0002734_abnormal_mechanical_nocicepti | 1.73314123 |
| 37 | MP0004084_abnormal_cardiac_muscle | 1.72230629 |
| 38 | * MP0004085_abnormal_heartbeat | 1.72008738 |
| 39 | MP0002160_abnormal_reproductive_system | 1.71045313 |
| 40 | MP0009697_abnormal_copulation | 1.71030374 |
| 41 | MP0002822_catalepsy | 1.68912878 |
| 42 | MP0000049_abnormal_middle_ear | 1.67645182 |
| 43 | MP0004036_abnormal_muscle_relaxation | 1.65018650 |
| 44 | MP0003646_muscle_fatigue | 1.64691089 |
| 45 | MP0005379_endocrine/exocrine_gland_phen | 1.64653698 |
| 46 | MP0004145_abnormal_muscle_electrophysio | 1.63373883 |
| 47 | MP0005330_cardiomyopathy | 1.62055332 |
| 48 | MP0004510_myositis | 1.58432995 |
| 49 | MP0002735_abnormal_chemical_nociception | 1.58185434 |
| 50 | MP0008569_lethality_at_weaning | 1.56565059 |
| 51 | MP0006138_congestive_heart_failure | 1.55736634 |
| 52 | MP0002090_abnormal_vision | 1.54271277 |
| 53 | MP0004133_heterotaxia | 1.52925806 |
| 54 | MP0005167_abnormal_blood-brain_barrier | 1.52681198 |
| 55 | MP0004858_abnormal_nervous_system | 1.44903058 |
| 56 | MP0002876_abnormal_thyroid_physiology | 1.44125381 |
| 57 | * MP0002972_abnormal_cardiac_muscle | 1.42307690 |
| 58 | MP0002557_abnormal_social/conspecific_i | 1.39135325 |
| 59 | MP0003137_abnormal_impulse_conducting | 1.38741379 |
| 60 | MP0000372_irregular_coat_pigmentation | 1.38539006 |
| 61 | MP0002139_abnormal_hepatobiliary_system | 1.38026487 |
| 62 | MP0005386_behavior/neurological_phenoty | 1.37613734 |
| 63 | MP0004924_abnormal_behavior | 1.37613734 |
| 64 | MP0003633_abnormal_nervous_system | 1.35969098 |
| 65 | MP0004233_abnormal_muscle_weight | 1.35118792 |
| 66 | MP0001970_abnormal_pain_threshold | 1.34052165 |
| 67 | * MP0005620_abnormal_muscle_contractility | 1.34001164 |
| 68 | MP0006072_abnormal_retinal_apoptosis | 1.33544863 |
| 69 | MP0000778_abnormal_nervous_system | 1.31284890 |
| 70 | MP0000613_abnormal_salivary_gland | 1.29314536 |
| 71 | MP0002638_abnormal_pupillary_reflex | 1.28073992 |
| 72 | MP0002733_abnormal_thermal_nociception | 1.25855938 |
| 73 | MP0001984_abnormal_olfaction | 1.23377162 |
| 74 | MP0002909_abnormal_adrenal_gland | 1.21753105 |
| 75 | MP0008877_abnormal_DNA_methylation | 1.21251194 |
| 76 | MP0003879_abnormal_hair_cell | 1.20545718 |
| 77 | MP0000749_muscle_degeneration | 1.17776987 |
| 78 | * MP0008872_abnormal_physiological_respon | 1.17098708 |
| 79 | MP0005253_abnormal_eye_physiology | 1.15890393 |
| 80 | MP0001502_abnormal_circadian_rhythm | 1.15476823 |
| 81 | MP0004130_abnormal_muscle_cell | 1.14650346 |
| 82 | MP0003828_pulmonary_edema | 1.13840876 |
| 83 | MP0002882_abnormal_neuron_morphology | 1.13267320 |
| 84 | MP0002184_abnormal_innervation | 1.11828277 |
| 85 | MP0002127_abnormal_cardiovascular_syste | 1.11164094 |
| 86 | MP0002332_abnormal_exercise_endurance | 1.09163890 |
| 87 | MP0002066_abnormal_motor_capabilities/c | 1.08559184 |
| 88 | MP0003690_abnormal_glial_cell | 1.08391259 |
| 89 | MP0005389_reproductive_system_phenotype | 1.08270014 |
| 90 | MP0001905_abnormal_dopamine_level | 1.07140697 |
| 91 | MP0003075_altered_response_to | 1.06723148 |
| 92 | MP0001188_hyperpigmentation | 1.06651491 |
| 93 | MP0003787_abnormal_imprinting | 1.05709077 |
| 94 | MP0005645_abnormal_hypothalamus_physiol | 1.05085182 |
| 95 | MP0009384_cardiac_valve_regurgitation | 1.03894217 |
| 96 | MP0004885_abnormal_endolymph | 1.03683760 |
| 97 | MP0002229_neurodegeneration | 1.02835897 |
| 98 | MP0003631_nervous_system_phenotype | 1.02083548 |
| 99 | MP0006276_abnormal_autonomic_nervous | 1.01781313 |
| 100 | MP0000678_abnormal_parathyroid_gland | 1.01303216 |
| 101 | MP0009250_abnormal_appendicular_skeleto | 1.00410795 |
| 102 | MP0002108_abnormal_muscle_morphology | 0.97884305 |
| 103 | MP0005595_abnormal_vascular_smooth | 0.97433810 |
| 104 | MP0004087_abnormal_muscle_fiber | 0.95572072 |
| 105 | MP0005646_abnormal_pituitary_gland | 0.93498107 |
| 106 | MP0004811_abnormal_neuron_physiology | 0.92631953 |
| 107 | * MP0001544_abnormal_cardiovascular_syste | 0.91368882 |
| 108 | * MP0005385_cardiovascular_system_phenoty | 0.91368882 |
| 109 | * MP0005535_abnormal_body_temperature | 0.91253743 |
| 110 | MP0005084_abnormal_gallbladder_morpholo | 0.90979216 |
| 111 | MP0005623_abnormal_meninges_morphology | 0.89764246 |
| 112 | MP0008874_decreased_physiological_sensi | 0.88021705 |
| 113 | MP0000955_abnormal_spinal_cord | 0.80484882 |
| 114 | MP0005165_increased_susceptibility_to | 0.79998271 |
| 115 | MP0010368_abnormal_lymphatic_system | 0.79492925 |
| 116 | MP0001963_abnormal_hearing_physiology | 0.78277973 |
| 117 | MP0000013_abnormal_adipose_tissue | 0.78052703 |
| 118 | MP0004142_abnormal_muscle_tone | 0.77712293 |
| 119 | MP0000026_abnormal_inner_ear | 0.77624712 |
| 120 | MP0002106_abnormal_muscle_physiology | 0.77281992 |
| 121 | MP0003938_abnormal_ear_development | 0.76977750 |
| 122 | MP0004742_abnormal_vestibular_system | 0.76570868 |
| 123 | MP0005409_darkened_coat_color | 0.76278481 |
| 124 | MP0003950_abnormal_plasma_membrane | 0.75598235 |
| 125 | MP0005195_abnormal_posterior_eye | 0.75251378 |
| 126 | MP0001944_abnormal_pancreas_morphology | 0.74632058 |
| 127 | MP0008775_abnormal_heart_ventricle | 0.73982485 |
| 128 | MP0002152_abnormal_brain_morphology | 0.73654531 |
| 129 | MP0002653_abnormal_ependyma_morphology | 0.73126267 |
| 130 | MP0001177_atelectasis | 0.73023503 |
| 131 | MP0000604_amyloidosis | 0.72927958 |
| 132 | MP0003937_abnormal_limbs/digits/tail_de | 0.72888150 |
| 133 | MP0002928_abnormal_bile_duct | 0.72886281 |
| 134 | MP0005448_abnormal_energy_balance | 0.70865024 |
| 135 | MP0005310_abnormal_salivary_gland | 0.70694175 |
| 136 | MP0002752_abnormal_somatic_nervous | 0.70416662 |
| 137 | MP0000230_abnormal_systemic_arterial | 0.70152892 |
| 138 | MP0010386_abnormal_urinary_bladder | 0.69712103 |
| 139 | MP0003195_calcinosis | 0.69177995 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 6.85836116 |
| 2 | Epileptic encephalopathy (HP:0200134) | 5.20318900 |
| 3 | Focal seizures (HP:0007359) | 4.65903581 |
| 4 | Atonic seizures (HP:0010819) | 4.61579295 |
| 5 | Hyperventilation (HP:0002883) | 4.33088356 |
| 6 | Sudden death (HP:0001699) | 4.19803853 |
| 7 | Absence seizures (HP:0002121) | 4.09315456 |
| 8 | Pendular nystagmus (HP:0012043) | 4.08098531 |
| 9 | Syncope (HP:0001279) | 3.92544735 |
| 10 | Febrile seizures (HP:0002373) | 3.86604218 |
| 11 | Visual hallucinations (HP:0002367) | 3.83756889 |
| 12 | Myokymia (HP:0002411) | 3.80851530 |
| 13 | Anomalous pulmonary venous return (HP:0010772) | 3.78785378 |
| 14 | Dyschromatopsia (HP:0007641) | 3.67669098 |
| 15 | Generalized tonic-clonic seizures (HP:0002069) | 3.62972745 |
| 16 | Dialeptic seizures (HP:0011146) | 3.60833299 |
| 17 | Abnormality of the pulmonary veins (HP:0011718) | 3.58591877 |
| 18 | Calf muscle hypertrophy (HP:0008981) | 3.33616539 |
| 19 | Short phalanx of the thumb (HP:0009660) | 3.31159657 |
| 20 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.27514781 |
| 21 | Neoplasm of the heart (HP:0100544) | 3.25962283 |
| 22 | Type II lissencephaly (HP:0007260) | 3.20187410 |
| 23 | Broad-based gait (HP:0002136) | 3.18177685 |
| 24 | Atrial fibrillation (HP:0005110) | 3.17937513 |
| 25 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 3.12994446 |
| 26 | Short 4th metacarpal (HP:0010044) | 3.12994446 |
| 27 | True hermaphroditism (HP:0010459) | 3.12424796 |
| 28 | Dysdiadochokinesis (HP:0002075) | 3.09567626 |
| 29 | Primary atrial arrhythmia (HP:0001692) | 3.07960071 |
| 30 | Abnormality of the calf musculature (HP:0001430) | 3.02523966 |
| 31 | Progressive cerebellar ataxia (HP:0002073) | 2.98867037 |
| 32 | Pancreatic fibrosis (HP:0100732) | 2.95155079 |
| 33 | Poor eye contact (HP:0000817) | 2.92040352 |
| 34 | Supraventricular tachycardia (HP:0004755) | 2.91978681 |
| 35 | Methylmalonic acidemia (HP:0002912) | 2.89915654 |
| 36 | Supraventricular arrhythmia (HP:0005115) | 2.89124685 |
| 37 | 3-Methylglutaconic aciduria (HP:0003535) | 2.82974342 |
| 38 | Hypothermia (HP:0002045) | 2.81001319 |
| 39 | Amblyopia (HP:0000646) | 2.79550874 |
| 40 | Cerebral inclusion bodies (HP:0100314) | 2.79088121 |
| 41 | Abolished electroretinogram (ERG) (HP:0000550) | 2.71955273 |
| 42 | Prolonged QT interval (HP:0001657) | 2.66103799 |
| 43 | Congenital stationary night blindness (HP:0007642) | 2.63796740 |
| 44 | Abnormality of binocular vision (HP:0011514) | 2.62507855 |
| 45 | Diplopia (HP:0000651) | 2.62507855 |
| 46 | Drooling (HP:0002307) | 2.61919007 |
| 47 | Excessive salivation (HP:0003781) | 2.61919007 |
| 48 | Hemiparesis (HP:0001269) | 2.61241945 |
| 49 | Congenital sensorineural hearing impairment (HP:0008527) | 2.60850970 |
| 50 | Absent/shortened dynein arms (HP:0200106) | 2.60770527 |
| 51 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.60770527 |
| 52 | Pancreatic cysts (HP:0001737) | 2.60473252 |
| 53 | Exercise-induced myalgia (HP:0003738) | 2.59703819 |
| 54 | Aplasia/Hypoplasia of the phalanges of the thumb (HP:0009658) | 2.58902110 |
| 55 | Impaired social interactions (HP:0000735) | 2.57120693 |
| 56 | Abnormal social behavior (HP:0012433) | 2.57120693 |
| 57 | Down-sloping shoulders (HP:0200021) | 2.56440186 |
| 58 | Abnormality of the parietal bone (HP:0002696) | 2.55833202 |
| 59 | Hemiplegia (HP:0002301) | 2.54820624 |
| 60 | Abnormality of the 4th metacarpal (HP:0010012) | 2.54057511 |
| 61 | Neurofibrillary tangles (HP:0002185) | 2.51188316 |
| 62 | Central scotoma (HP:0000603) | 2.50381566 |
| 63 | Vertebral fusion (HP:0002948) | 2.47092761 |
| 64 | Gaze-evoked nystagmus (HP:0000640) | 2.46698632 |
| 65 | Nephronophthisis (HP:0000090) | 2.44146914 |
| 66 | Deformed sella turcica (HP:0002681) | 2.42588675 |
| 67 | Anxiety (HP:0000739) | 2.42531187 |
| 68 | Split foot (HP:0001839) | 2.42199034 |
| 69 | Dysmetria (HP:0001310) | 2.41169651 |
| 70 | Inability to walk (HP:0002540) | 2.39785275 |
| 71 | Abnormality of the nasal septum (HP:0000419) | 2.38960470 |
| 72 | Abnormality of macular pigmentation (HP:0008002) | 2.38541355 |
| 73 | Homocystinuria (HP:0002156) | 2.38166715 |
| 74 | Abnormality of homocysteine metabolism (HP:0010919) | 2.38166715 |
| 75 | Truncal ataxia (HP:0002078) | 2.34474084 |
| 76 | Abnormality of the renal cortex (HP:0011035) | 2.34203845 |
| 77 | Thickened helices (HP:0000391) | 2.33204937 |
| 78 | Increased corneal curvature (HP:0100692) | 2.33094712 |
| 79 | Keratoconus (HP:0000563) | 2.33094712 |
| 80 | Supranuclear gaze palsy (HP:0000605) | 2.32985602 |
| 81 | Abnormality of midbrain morphology (HP:0002418) | 2.32635295 |
| 82 | Molar tooth sign on MRI (HP:0002419) | 2.32635295 |
| 83 | Bundle branch block (HP:0011710) | 2.30083240 |
| 84 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.28157155 |
| 85 | Aplasia of the phalanges of the hand (HP:0009802) | 2.28157155 |
| 86 | Aplasia involving bones of the extremities (HP:0009825) | 2.28157155 |
| 87 | Status epilepticus (HP:0002133) | 2.27021596 |
| 88 | Epileptiform EEG discharges (HP:0011182) | 2.25749582 |
| 89 | Abnormal EKG (HP:0003115) | 2.23454430 |
| 90 | Ventricular fibrillation (HP:0001663) | 2.22451105 |
| 91 | Oligodactyly (hands) (HP:0001180) | 2.22007896 |
| 92 | Dysmetric saccades (HP:0000641) | 2.20737367 |
| 93 | Depression (HP:0000716) | 2.20560530 |
| 94 | Absent speech (HP:0001344) | 2.19960245 |
| 95 | Posterior subcapsular cataract (HP:0007787) | 2.19109306 |
| 96 | Confusion (HP:0001289) | 2.18963649 |
| 97 | Methylmalonic aciduria (HP:0012120) | 2.18456311 |
| 98 | Spinal muscular atrophy (HP:0007269) | 2.17470908 |
| 99 | Cerebellar dysplasia (HP:0007033) | 2.16148768 |
| 100 | Progressive inability to walk (HP:0002505) | 2.15578349 |
| 101 | Broad ribs (HP:0000885) | 2.15124960 |
| 102 | Rapidly progressive (HP:0003678) | 2.13481456 |
| 103 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.13106214 |
| 104 | Hydroureter (HP:0000072) | 2.10993942 |
| 105 | Choroideremia (HP:0001139) | 2.09579794 |
| 106 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.09357973 |
| 107 | Ventricular tachycardia (HP:0004756) | 2.06908154 |
| 108 | Renal cortical cysts (HP:0000803) | 2.06876196 |
| 109 | Hamartoma of the eye (HP:0010568) | 2.06864880 |
| 110 | Action tremor (HP:0002345) | 2.06571062 |
| 111 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.05169436 |
| 112 | Optic disc pallor (HP:0000543) | 2.04999172 |
| 113 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.03541323 |
| 114 | Stereotypic behavior (HP:0000733) | 2.03044763 |
| 115 | Congenital, generalized hypertrichosis (HP:0004540) | 2.02431411 |
| 116 | EEG with generalized epileptiform discharges (HP:0011198) | 2.02137722 |
| 117 | Arterial tortuosity (HP:0005116) | 2.00967372 |
| 118 | Porencephaly (HP:0002132) | 2.00495401 |
| 119 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.99877238 |
| 120 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.99877238 |
| 121 | Genetic anticipation (HP:0003743) | 1.99761273 |
| 122 | Late onset (HP:0003584) | 1.99576172 |
| 123 | Ventricular arrhythmia (HP:0004308) | 1.99528769 |
| 124 | Abnormality of the sella turcica (HP:0002679) | 1.98424005 |
| 125 | Cerebral hemorrhage (HP:0001342) | 1.97488146 |
| 126 | Left ventricular hypertrophy (HP:0001712) | 1.97354990 |
| 127 | Severe muscular hypotonia (HP:0006829) | 1.96872619 |
| 128 | Postural instability (HP:0002172) | 1.95642177 |
| 129 | Impaired smooth pursuit (HP:0007772) | 1.95126382 |
| 130 | Hypoplastic nipples (HP:0002557) | 1.94965824 |
| 131 | Hepatocellular necrosis (HP:0001404) | 1.94534456 |
| 132 | Athetosis (HP:0002305) | 1.92917049 |
| 133 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.92095428 |
| 134 | Acute necrotizing encephalopathy (HP:0006965) | 1.92055072 |
| 135 | Scotoma (HP:0000575) | 1.91830519 |
| 136 | Mitochondrial inheritance (HP:0001427) | 1.91056194 |
| 137 | Insidious onset (HP:0003587) | 1.90145864 |
| 138 | Termporal pattern (HP:0011008) | 1.90145864 |
| 139 | Goiter (HP:0000853) | 1.89922122 |
| 140 | Carpal bone hypoplasia (HP:0001498) | 1.89717317 |
| 141 | Septo-optic dysplasia (HP:0100842) | 1.88940481 |
| 142 | Neoplasm of the oral cavity (HP:0100649) | 1.88916548 |
| 143 | Pheochromocytoma (HP:0002666) | 1.88768247 |
| 144 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.87911462 |
| 145 | Chorioretinal atrophy (HP:0000533) | 1.87778013 |
| 146 | Abnormal eating behavior (HP:0100738) | 1.87221284 |
| 147 | Furrowed tongue (HP:0000221) | 1.86619928 |
| 148 | Severe visual impairment (HP:0001141) | 1.86018362 |
| 149 | EMG: myopathic abnormalities (HP:0003458) | 1.85852841 |
| 150 | Oral leukoplakia (HP:0002745) | 1.85405664 |
| 151 | Agitation (HP:0000713) | 1.84660234 |
| 152 | Abnormality of vitamin B metabolism (HP:0004340) | 1.84343543 |
| 153 | Hypoplasia of the uterus (HP:0000013) | 1.83931081 |
| 154 | Abnormal ciliary motility (HP:0012262) | 1.83813683 |
| 155 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 1.83492630 |
| 156 | Short 1st metacarpal (HP:0010034) | 1.83492630 |
| 157 | Tachypnea (HP:0002789) | 1.83134238 |
| 158 | Generalized myoclonic seizures (HP:0002123) | 1.82997907 |
| 159 | Abnormality of the renal medulla (HP:0100957) | 1.81561326 |
| 160 | Cystic liver disease (HP:0006706) | 1.81450470 |
| 161 | Retinal atrophy (HP:0001105) | 1.81149743 |
| 162 | Hypoplasia of the pons (HP:0012110) | 1.78941693 |
| 163 | Obstructive sleep apnea (HP:0002870) | 1.78674892 |
| 164 | Synostosis involving the elbow (HP:0003938) | 1.78604545 |
| 165 | Humeroradial synostosis (HP:0003041) | 1.78604545 |
| 166 | Retinal dysplasia (HP:0007973) | 1.78389180 |
| 167 | Male pseudohermaphroditism (HP:0000037) | 1.78339338 |
| 168 | Progressive macrocephaly (HP:0004481) | 1.78097564 |
| 169 | Abnormality of salivation (HP:0100755) | 1.78062306 |
| 170 | Decreased circulating renin level (HP:0003351) | 1.77830292 |
| 171 | Optic nerve hypoplasia (HP:0000609) | 1.77587319 |
| 172 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.77297594 |
| 173 | Subaortic stenosis (HP:0001682) | 1.75932019 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 4.80652892 |
| 2 | FRK | 3.96309120 |
| 3 | NTRK3 | 3.71695613 |
| 4 | ADRBK2 | 3.45708494 |
| 5 | CASK | 3.07248233 |
| 6 | EPHA3 | 2.99396316 |
| 7 | RIPK4 | 2.89495554 |
| 8 | MAP3K4 | 2.59851754 |
| 9 | MAP3K9 | 2.38009088 |
| 10 | DAPK2 | 2.32552817 |
| 11 | MAP2K7 | 2.22174475 |
| 12 | MYLK | 1.91617947 |
| 13 | GRK7 | 1.90382161 |
| 14 | PLK2 | 1.89015527 |
| 15 | LMTK2 | 1.88262506 |
| 16 | PTK2B | 1.86621880 |
| 17 | PRKCI | 1.78344960 |
| 18 | GRK5 | 1.78301945 |
| 19 | MAP2K4 | 1.76324566 |
| 20 | BMPR1B | 1.72499885 |
| 21 | VRK1 | 1.72199843 |
| 22 | STK4 | 1.71548462 |
| 23 | BMPR2 | 1.69857819 |
| 24 | PRKD2 | 1.69564792 |
| 25 | DMPK | 1.69421786 |
| 26 | MINK1 | 1.63216935 |
| 27 | AKT3 | 1.62508847 |
| 28 | PNCK | 1.60559061 |
| 29 | ZAK | 1.60453954 |
| 30 | PAK6 | 1.58922744 |
| 31 | TLK1 | 1.54081768 |
| 32 | MAP3K12 | 1.52865797 |
| 33 | SIK2 | 1.42463842 |
| 34 | MAP3K13 | 1.38787889 |
| 35 | KSR2 | 1.36275349 |
| 36 | ACVR1B | 1.34438628 |
| 37 | CAMK2A | 1.31722584 |
| 38 | NTRK2 | 1.29639693 |
| 39 | FES | 1.28392749 |
| 40 | MAPK12 | 1.28052183 |
| 41 | FGR | 1.27716852 |
| 42 | DAPK1 | 1.26802555 |
| 43 | CDK5 | 1.25867669 |
| 44 | STK38 | 1.24066951 |
| 45 | PHKG1 | 1.16026921 |
| 46 | PHKG2 | 1.16026921 |
| 47 | MAP4K2 | 1.15530550 |
| 48 | INSRR | 1.15035554 |
| 49 | TNIK | 1.13144224 |
| 50 | MARK1 | 1.12113186 |
| 51 | PAK3 | 1.09090733 |
| 52 | PDK2 | 1.08956691 |
| 53 | TAOK3 | 1.08275881 |
| 54 | TAF1 | 1.07491865 |
| 55 | TGFBR2 | 1.07475789 |
| 56 | TIE1 | 1.05622554 |
| 57 | PRPF4B | 1.03401526 |
| 58 | NTRK1 | 1.01021912 |
| 59 | MAP2K6 | 0.99775605 |
| 60 | CAMK1 | 0.99491956 |
| 61 | FGFR2 | 0.98377943 |
| 62 | PRKAA1 | 0.98133300 |
| 63 | PDK4 | 0.96460047 |
| 64 | PDK3 | 0.96460047 |
| 65 | PINK1 | 0.93043745 |
| 66 | CAMKK1 | 0.92254375 |
| 67 | CAMK2B | 0.91998709 |
| 68 | CAMK2D | 0.91109368 |
| 69 | CCNB1 | 0.90695373 |
| 70 | PRKCE | 0.90160299 |
| 71 | PKN1 | 0.88777470 |
| 72 | NUAK1 | 0.87720039 |
| 73 | MST4 | 0.87470706 |
| 74 | KSR1 | 0.85694366 |
| 75 | MAPK7 | 0.85349858 |
| 76 | FER | 0.84933257 |
| 77 | NME1 | 0.84064252 |
| 78 | CAMK1D | 0.83491263 |
| 79 | WNK3 | 0.83329875 |
| 80 | PRKD3 | 0.83055557 |
| 81 | CAMK1G | 0.81914319 |
| 82 | MAPKAPK3 | 0.81246522 |
| 83 | PRKCG | 0.80253380 |
| 84 | GRK1 | 0.79451560 |
| 85 | MAP3K2 | 0.77580194 |
| 86 | RPS6KA5 | 0.76662056 |
| 87 | RAF1 | 0.73245501 |
| 88 | SGK1 | 0.72614936 |
| 89 | CSNK1G1 | 0.72393265 |
| 90 | CDK19 | 0.71635217 |
| 91 | AURKA | 0.70725449 |
| 92 | ARAF | 0.68445716 |
| 93 | MAP3K1 | 0.67499624 |
| 94 | SGK223 | 0.67133050 |
| 95 | SGK494 | 0.67133050 |
| 96 | MAPK13 | 0.66288555 |
| 97 | PDK1 | 0.66026872 |
| 98 | PDPK1 | 0.66008383 |
| 99 | DYRK1A | 0.65621509 |
| 100 | SGK2 | 0.64944594 |
| 101 | MOS | 0.62623430 |
| 102 | TNK2 | 0.62097508 |
| 103 | CDC42BPA | 0.60535843 |
| 104 | MAP3K7 | 0.60425938 |
| 105 | PRKCZ | 0.58936644 |
| 106 | RET | 0.58914290 |
| 107 | CDK3 | 0.58878594 |
| 108 | MUSK | 0.56621528 |
| 109 | DAPK3 | 0.56218862 |
| 110 | STK11 | 0.55170169 |
| 111 | ROCK2 | 0.54520575 |
| 112 | CDK18 | 0.54327853 |
| 113 | MAPK15 | 0.54210376 |
| 114 | CDK15 | 0.53553936 |
| 115 | MAP2K1 | 0.53434296 |
| 116 | PRKD1 | 0.53375490 |
| 117 | CAMK2G | 0.52567398 |
| 118 | * PRKACA | 0.51821351 |
| 119 | MAPKAPK5 | 0.51300120 |
| 120 | OBSCN | 0.51197033 |
| 121 | PRKCQ | 0.51169521 |
| 122 | TEC | 0.50993728 |
| 123 | CSNK1A1L | 0.50594493 |
| 124 | BRSK2 | 0.50077776 |
| 125 | ADRBK1 | 0.50054987 |
| 126 | CSNK1A1 | 0.49984363 |
| 127 | PRKCH | 0.49305933 |
| 128 | MARK2 | 0.48255911 |
| 129 | CDK14 | 0.48148925 |
| 130 | MAP3K6 | 0.47846507 |
| 131 | TTN | 0.47814454 |
| 132 | RPS6KA6 | 0.47663869 |
| 133 | CSNK1G3 | 0.47283510 |
| 134 | OXSR1 | 0.47110675 |
| 135 | UHMK1 | 0.43844675 |
| 136 | CAMK4 | 0.43711516 |
| 137 | CSNK1G2 | 0.43333513 |
| 138 | STK39 | 0.43144583 |
| 139 | PIK3CA | 0.42707218 |
| 140 | ROCK1 | 0.42279558 |
| 141 | RPS6KA3 | 0.41835150 |
| 142 | PRKCA | 0.38761543 |
| 143 | SGK3 | 0.36805391 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.19820171 |
| 2 | Phototransduction_Homo sapiens_hsa04744 | 2.87077330 |
| 3 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 2.82578085 |
| 4 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.74461608 |
| 5 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.51711408 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.46601340 |
| 7 | Long-term potentiation_Homo sapiens_hsa04720 | 2.45048627 |
| 8 | Alcoholism_Homo sapiens_hsa05034 | 2.44189508 |
| 9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.34660274 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 2.33794193 |
| 11 | GABAergic synapse_Homo sapiens_hsa04727 | 2.29898300 |
| 12 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.28658296 |
| 13 | * Salivary secretion_Homo sapiens_hsa04970 | 2.24171710 |
| 14 | Olfactory transduction_Homo sapiens_hsa04740 | 2.16467002 |
| 15 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.11749433 |
| 16 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.06089552 |
| 17 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.99704257 |
| 18 | * Renin secretion_Homo sapiens_hsa04924 | 1.98202172 |
| 19 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.90833519 |
| 20 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.90410515 |
| 21 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.80486657 |
| 22 | Taste transduction_Homo sapiens_hsa04742 | 1.77664792 |
| 23 | Insulin secretion_Homo sapiens_hsa04911 | 1.76810612 |
| 24 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.74657075 |
| 25 | * Calcium signaling pathway_Homo sapiens_hsa04020 | 1.68494283 |
| 26 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.67764060 |
| 27 | * Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.64014043 |
| 28 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.62396483 |
| 29 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.61156999 |
| 30 | * Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.56796216 |
| 31 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.55288437 |
| 32 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.55223428 |
| 33 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.52863290 |
| 34 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.47862978 |
| 35 | Long-term depression_Homo sapiens_hsa04730 | 1.45805180 |
| 36 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.35861488 |
| 37 | * cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.34382835 |
| 38 | * cAMP signaling pathway_Homo sapiens_hsa04024 | 1.33718424 |
| 39 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.27177562 |
| 40 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.26973054 |
| 41 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.22272043 |
| 42 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.21256409 |
| 43 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.20687441 |
| 44 | Alzheimers disease_Homo sapiens_hsa05010 | 1.20175557 |
| 45 | Cocaine addiction_Homo sapiens_hsa05030 | 1.18192016 |
| 46 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.17182011 |
| 47 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.15350154 |
| 48 | * Gap junction_Homo sapiens_hsa04540 | 1.12416418 |
| 49 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.10172004 |
| 50 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.10045591 |
| 51 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.09190456 |
| 52 | Histidine metabolism_Homo sapiens_hsa00340 | 1.08628373 |
| 53 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.07407371 |
| 54 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.06564326 |
| 55 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.01435232 |
| 56 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.00143606 |
| 57 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.98968042 |
| 58 | Melanogenesis_Homo sapiens_hsa04916 | 0.97083648 |
| 59 | Melanoma_Homo sapiens_hsa05218 | 0.95060758 |
| 60 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.93983690 |
| 61 | * Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.92298326 |
| 62 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.91517811 |
| 63 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.90337466 |
| 64 | Axon guidance_Homo sapiens_hsa04360 | 0.89945155 |
| 65 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.88354766 |
| 66 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.88023170 |
| 67 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.87604700 |
| 68 | Parkinsons disease_Homo sapiens_hsa05012 | 0.86380646 |
| 69 | Homologous recombination_Homo sapiens_hsa03440 | 0.84923509 |
| 70 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.82847497 |
| 71 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.82676779 |
| 72 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.82181802 |
| 73 | Glioma_Homo sapiens_hsa05214 | 0.78749179 |
| 74 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.78727358 |
| 75 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.78613188 |
| 76 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.78465846 |
| 77 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.77692748 |
| 78 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.76186806 |
| 79 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.76160124 |
| 80 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.75430313 |
| 81 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.74036702 |
| 82 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.73618517 |
| 83 | * Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.73597142 |
| 84 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.72797983 |
| 85 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.69633660 |
| 86 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.69508328 |
| 87 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.68523718 |
| 88 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.68021559 |
| 89 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.66651669 |
| 90 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.64445079 |
| 91 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.62969864 |
| 92 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.62171693 |
| 93 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.60407485 |
| 94 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.59874470 |
| 95 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.59565508 |
| 96 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.59365936 |
| 97 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.58043671 |
| 98 | Bile secretion_Homo sapiens_hsa04976 | 0.57762809 |
| 99 | Huntingtons disease_Homo sapiens_hsa05016 | 0.57719465 |
| 100 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.57560195 |
| 101 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.57469943 |
| 102 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.57274062 |
| 103 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.55277849 |
| 104 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.55015316 |
| 105 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.54726907 |
| 106 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.52616016 |
| 107 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.52553926 |
| 108 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.51396153 |
| 109 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.51104839 |
| 110 | ABC transporters_Homo sapiens_hsa02010 | 0.50979221 |
| 111 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.50860216 |
| 112 | Prion diseases_Homo sapiens_hsa05020 | 0.48855785 |
| 113 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.47537504 |
| 114 | Circadian rhythm_Homo sapiens_hsa04710 | 0.46682255 |
| 115 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.46328989 |
| 116 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.45594802 |
| 117 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.44155641 |
| 118 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.43033415 |
| 119 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.41268732 |
| 120 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.41238472 |
| 121 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.40077266 |
| 122 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.38026459 |
| 123 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.35483711 |
| 124 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.34066759 |
| 125 | Platelet activation_Homo sapiens_hsa04611 | 0.33873841 |
| 126 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.33778073 |
| 127 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.32652856 |
| 128 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.32576219 |
| 129 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.29473783 |
| 130 | Mineral absorption_Homo sapiens_hsa04978 | 0.28886052 |
| 131 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.28030691 |
| 132 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.27277157 |
| 133 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.26930766 |
| 134 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.26191710 |
| 135 | Focal adhesion_Homo sapiens_hsa04510 | 0.25310552 |
| 136 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.25271970 |
| 137 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.24513137 |

